Examples of 'patients who develop' in a sentence
Meaning of "patients who develop"
patients who develop - Refers to individuals who experience or develop a particular condition, symptom, or illness
How to use "patients who develop" in a sentence
Basic
Advanced
patients who develop
And elective patients who develop complications.
Discontinuation of vinflunine should be considered in patients who develop cardiac ischaemia.
Patients who develop systemic symptoms need hospitalization.
Discontinue treatment in patients who develop evidence of hepatic decompensation.
Patients who develop complications after hormonal stimulation.
Crizotinib should be discontinued in patients who develop gastrointestinal perforation.
Patients who develop a.
Treatment should be stopped in patients who develop liver problems.
Patients who develop fever should promptly seek medical attention.
The majority of the patients who develop neuromas are women.
Patients who develop cardiac arrest will be pulsesless and unconscious.
Cabozantinib should be discontinued in patients who develop nephrotic syndrome.
Patients who develop adverse reactions should receive appropriate treatment.
Therapy should be permanently discontinued in patients who develop gastrointestinal perforation.
Patients who develop vasospasm do worse than those who do not.
See also
Monitoring may help to identify patients who develop cardiac dysfunction.
Patients who develop benign intracranial hypertension should discontinue isotretinoin immediately.
Treatment should be discontinued in patients who develop evidence of hepatic decompensation.
Patients who develop marked hypercalcemia or marked hyperphosphatemia immediately suspend treatment.
Interruption of treatment should be considered in patients who develop unexplained cytopenia.
The number of patients who develop secondary cancers is small.
Drugs inhibiting peristalsis are contraindicated in patients who develop serious diarrhoea.
Patients who develop SSIs suffer significant debilitation and increased risk.
The doctor may interrupt treatment in patients who develop a serious infection.
Therefore patients who develop fever should be monitored for opioid adverse reactions.
Therapy should be permanently discontinued in patients who develop arterial thromboembolic events.
All patients who develop a rash while taking rufinamide must be closely monitored.
Therapy should be permanently discontinued in patients who develop arterial thromboembolic reactions.
Patients who develop thyroid dysfunction should be treated as per standard medical practice.
They can kill up to about half of patients who develop bloodstream infections.
Patients who develop metabolic acidosis were treated with the infusion of sodium bicarbonate.
Central cord syndrome is common for patients who develop neurologic deficits.
Patients who develop symptoms of hyperglycemia should have a serum fasting glucose test.
The dose should also be reduced temporarily in patients who develop diarrhoea.
Most patients who develop complications like meningoencephalitis usually have a favorable outlook.
Increasing the dose may be harmful to patients who develop such symptoms.
Lung cancer patients who develop brain metastases usually have a poor prognosis.
Interruption of deferasirox therapy should be considered in patients who develop metabolic acidosis.
Surgical patients who develop hyperglycemia also show an increased risk of adverse outcomes.
Serum LFTs should be monitored more frequently in patients who develop elevations.
Patients who develop an upset stomach can also experience a temporary loss of appetite.
Pegasys treatment should be discontinued in patients who develop new or worsening ophthalmologic disorders.
Combination therapy with alpha interferons should be discontinued in patients who develop new or.
Patients who develop neutropenia should be monitored closely for the development of fever or infection.
Discontinuation of PegIntron should be considered in patients who develop new or worsening ophthalmological disorders.
Patients who develop these symptoms should be reassessed and their treatment regimens evaluated.
Discontinuation of IntronA should be considered in patients who develop new or worsening ophthalmological disorders.
Patients who develop signs and symptoms suggestive of pancreatitis should be evaluated and monitored.
Discontinuation of ViraferonPeg should be considered in patients who develop new or worsening ophthalmological disorders.
Patients who develop symptoms should see their surgeon promptly for further evaluation.
You'll also be interested in:
Examples of using Develop
Show more
Develop training materials in the area of PPPs
Promoting clinics to develop and improve personality
Develop or review specific guidelines and recommendations
Examples of using Patients
Show more
Patients at the very heart of our mission
We have the best patients in the world
Patients also pay for essential drugs
